Slow potentials and interferences in evaluation of psychotropic drugs.
D000328:Adult; D014151:Anti-Anxiety Agents; D001143:Arousal / Q000187:drug effects; D001569:Benzodiazepines; D002540:Cerebral Cortex / Q000187:drug effects*; D003265:Contingent Negative Variation / Q000187:drug effects; D003984:Dibenzazepines / Q000494:pharmacology*; D004311:Double-Blind Method; D004569:Electroencephalography; D005071:Evoked Potentials / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011619:Psychotropic Drugs / Q000494:pharmacology*; D011724:Pyridazines / Q000494:pharmacology*
D014151:Anti-Anxiety Agents; D003984:Dibenzazepines; D011619:Psychotropic Drugs; D011724:Pyridazines; C006149:minaprine; D001569:Benzodiazepines; C006922:carpipramine